Crazy Volume Spikes for: Auris Medical Holding AG (NASDAQ:EARS)

This rating was issued on 3/15/16. As the past trend shows, Auris Medical Holding AG's stock price has plunged after earnings in 5 of the last 9 quarters.

Price Target is basically a projection of future price of a company's stock by the expert analysis of investment analysts or investment firms. It indicates oversold and overbought price levels for a stock. They now have a United States dollars 8 price target on the stock. The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.50.

Separately, Zacks Investment Research upgraded Auris Medical Holding AG from a "sell" rating to a "buy" rating and set a $1.25 price objective on the stock in a report on Monday, November 14th.

Auris Medical Holding AG is a holding and clinical-stage biopharmaceutical company focused on the development of products for the treatment of inner ear disorders. Their 52-Week High and Low are noted here.

Auris Medical Holding AG (EARS), a stock from Biotechnology Industry, has a value of $0.89 per share, noted a price change of 5.83% in recent trade close. Buy rating has been given by 2 analysts to the company stock.

Auris Medical Holding AG (NASDAQ:EARS) performed nicely this week, continuing its impressive near-term upward movement. The consensus recommendation by Thomson Reuters analysts is Buy and their mean rating for the stock is 1.00 on scale of 1-5. The firm's market cap is $30.52 million. The company reported its last quarter on Dec 16. Full-year profit views are for Auris Medical Holding AG to earn -$1.02 in current year and drop profits by almost 15.91% over last year's earnings of -$0.88. The company has a 1 Year high price target of $7. The stock is now moving above its 20-Day Simple Moving Average of -14.13% with the 50-Day Simple Moving Average of -14.13 percent. Their 50-Day Simple Moving Average is a difference of 2.64% from current levels. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2017/03/16/auris-medical-holding-ag-ears-posts-earnings-results-beats-expectations-by-0-13-eps.html.

The company shows its Return on Assets (ROA) value of -70.8%. The brokerage now has a "buy" rating on the stock. Likewise, the negative performance for the quarter was recorded as -4.14% and for the year was 20.39%, while the YTD performance remained at -6.21%. The Relative Volume value measured for Auris Medical Holding AG (NASDAQ:EARS) is 9.26.

Recommended News

  • Torrance high school baseball player killed in car crash

    A 21-year-old man was arrested on suspicion of vehicular manslaughter. "It's incredibly tragic", Coach Grady Sain said. Police are searching for the identity of a second driver, who fled the scene, according to the Daily Breeze .

    Samsung Galaxy Note 8 Rumors Roundup

    The Galaxy Note 8 may not be everyone's sole focus right now, what with the Galaxy S8 gearing up for a release date next month. If you're a Samsung Galaxy Note fan you'll know all about the little Samsung stylus and the fun you can have with it.
    Solar company Sungevity files for bankruptcy, agrees to sell assets

    Solar company Sungevity files for bankruptcy, agrees to sell assets

    In an announcement , California-based Sungevity reveals it has commenced voluntary Chapter 11 proceedings in U.S. If approved by the bankruptcy court, Northern Pacific would obtain essentially all of the assets of Sungevity.
  • New Veterans Affairs Secretary: Help those with other than honorable discharges

    New Veterans Affairs Secretary: Help those with other than honorable discharges

    After Trump selected him to be VA secretary, Shulkin has said he would not privatize the VA. "The 20 a day committing suicide are not getting the care they need".
    Buick Enclave Gets New Grille and Curvaceous Headlights

    Buick Enclave Gets New Grille and Curvaceous Headlights

    In another report, the 2018 Buick Enclave is expected to carry the 3.6-liter V-6 for the standard model. With regard to shape, the 2018 Buick Enclave is expected to have some resemblance with its predecessor.
    Microsoft Surface Book 2 Is Set for Immature Release Date?

    Microsoft Surface Book 2 Is Set for Immature Release Date?

    Meanwhile, the Surface Pro 4 price cut also suggests that the company is already planning to release the Microsoft Surface Pro 5. Microsoft is reportedly preparing to launch the successor of Surface Pro 4, the Microsoft Surface Pro 5 this year.
  • Paige Reportedly Hacked, Private Photos And Videos Leaked Online

    Paige Reportedly Hacked, Private Photos And Videos Leaked Online

    Many likened the incident to a 2014 hack that targeted dozens of celebrities, including Kate Upton and Jennifer Lawrence. However, it's unknown at this time if Paige was part of that specific hack or if this is separate.

    Antofagasta PLC reiterated as Underweight By JP Morgan

    In an analyst rating update on Thursday shares of Antofagasta PLC (LON:ANTO) had their rating reiterated by analysts at JP Morgan. The shares were bought at an average cost of GBX 211 ($2.58) per share, with a total value of £1,266,000 ($1,547,866.49).

    Celsion Corp. (NASDAQ:CLSN) has 1 year Price Target of $3

    The stock is now moving above its 20-Day Simple Moving Average of -23.86% with the 50-Day Simple Moving Average of -23.86 percent. In a transaction dated November 14, 2016, the shares were bought at an average price of $0.86, giving away a sum of $8,600.
  • Highly-venomous cobra escapes Florida home; residents panic

    Highly-venomous cobra escapes Florida home; residents panic

    Some people here are too scared to be in their own homes, fearing about not knowing where the venomous snake might be hiding. It hasn't been seen since and officials say they aren't sure if it's actually escaped the home.
    Windows 10 Creators Update Might Be Released Next Week

    Windows 10 Creators Update Might Be Released Next Week

    For example, user with the right permissions will be able to pause a feature update while allowing quality updates to continue. Windows Vista now has less than 1 percent global market share in terms of PC operating systems, according to Net Applications.

    Q1 2017 EPS Estimates for TG Therapeutics Inc Lowered by Analyst (TGTX)

    One research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company's stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website .

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.